Mariano Provencio Pulla

Has grant

Head of Medical Oncology Department at Puerta de Hierro University Hospital

Hospital Universitario Puerta del Hierro Majadahonda

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

INmunoSIGHT- Caracterización inmunológica y molecular en biopsia líquida de pacientes de cáncer de pulmón para inmunoterapia. RTC-2017-6502-1

Open Date: 2018-06-01

Close Date: 2021-12-01

Grant: Close

H2020-ICT-2017-1. BIGMEDILYTICS: Big Medical Data Analytics

Open Date: 2018-01-01

Close Date: 2021-01-01

Grant: Close

H2020-SC1-PM-18-2016.IASIS-Integration and analysis of heterogeneus Big Data for precision medicine and suggested treatments dor different types of patients.

Open Date: 2017-01-01

Close Date: 2020-01-01

Grant: Close

Sensitizing and resistant mutation quantification in urine and plasma samples. Correlation with radiographic imaging of tumors and survival.

Open Date: 2017-01-01

Close Date: 2019-01-01

Grant: Close

Estudio de la dinámica mutacional en pacientes de cáncer de pulmón no microcítico avanzado con mutación en EGFR en primera línea de tratamiento.

Open Date: 2016-01-01

Close Date: 2019-01-01

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (10)

Manuel Campos

Associate Professor

Universidad de Murcia

SPAIN

View details

Delvys Rodriguez-Abreu

Universidad de Las Palmas de Gran Canaria

SPAIN

View details

Florentino Hernando-Trancho. MD/PhD/Prof

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

SPAIN

View details

Pedro Sousa

Universidade de Aveiro

PORTUGAL

View details

Raquel Cumeras

Head of the Advanced Metabolomics team at GIOTEC group

Institut d'Investigació Sanitària Pere Virgili

SPAIN

View details

Gracinda Rita Guerreiro

Full Professor

Faculdade de Ciências da Universidade de Lisboa

PORTUGAL

View details

Joao Pimentao

Professor Auxiliar

Faculdade de Ciências da Universidade de Lisboa

PORTUGAL

View details

Joaquim Bosch-Barrera

Professor Associat Doctor

Universitat de Girona

SPAIN

View details

Javier De Castro

HEAD OF LUNG CANCER UNIT

La Paz University Hospital

SPAIN

View details

Esther Conde

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mariano Provencio Pulla

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Identification of non-actionable mutations with prognostic and predictive value in patients with advanced or metastatic non-small cell lung cancer

A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)

Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry

Quimioterapia más inmunoterapia como tratamiento neoadyuvante en el cáncer de pulmón de células no pequeñas CPCNP: caso clínico de un superviviente con enfermedad limítrofe para resecabilidad al diagnóstico

An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

Targeted therapy moves to earlier stages of non-small-cell lung cancer: emerging evidence, controversies and future challenges.

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

Use of immune checkpoint inhibitors in patients with solid tumors and pre-existing autoimmune or inflammatory disease: real-world data

Collaborators (10)

Manuel Campos

Delvys Rodriguez-Abreu

Florentino Hernando-Trancho. MD/PhD/Prof

Pedro Sousa

Raquel Cumeras

Gracinda Rita Guerreiro

Joao Pimentao

Joaquim Bosch-Barrera

Javier De Castro

Esther Conde

Make your next move.